Senores Pharmaceuticals Management Change
Senores Pharmaceuticals re-appointed Swapnil Shah as MD and Chetan Shah as WTD for three-year terms. Both appointments are subject to shareholder approval via postal ballot.
ALFA Filings
Every announcement, straight from the exchange
Every Senores Pharmaceuticals management change announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements
Senores Pharmaceuticals re-appointed Swapnil Shah as MD and Chetan Shah as WTD for three-year terms. Both appointments are subject to shareholder approval via postal ballot.
Senores Pharmaceuticals appointed Shilpa Sharma as Company Secretary and Viranchi Arvindbhai Shah as Independent Director. The board also approved a new ESOP scheme.
Senores Pharmaceuticals Limited has appointed Ms. Anjali Shah as Assistant Vice President - Finance, effective July 27, 2026. She brings over 10 years of experience in finance.
Senores Pharmaceuticals announced the cessation of its Company Secretary and Compliance Officer effective June 10, 2026. The company has designated other KMPs for disclosure responsibilities.